Dr. Maudsley has written a publication on Arrestin-based Receiver Signaling Paradigms: Potential therapeutic targets for complex age-related disorders.
The pharmacotherapeutic exploration of this signaling paradigm has created a drug-based field covering almost 50% of the current pharmacopoeia. From the revolutionary discoveries of the late 1990s to the present day, it is now clear, however, that GPCR can also generate productive signaling cascades by modulating the functionality of β-arrestin.
To learn more click here: https://www.pubfacts.com/detail/30546309/%CE%B2-Arrestin-Based-Receptor-Signaling-Paradigms-Potential-Therapeutic-Targets-for-Complex-Age-Related